WAT

IPG Introduces IMA Brand E-CO Flex SealMatic Fully Automatic Random WAT Case Sealer for E-Commerce

Retrieved on: 
水曜日, 5月 29, 2024
Automation, SIOC, IPG, RSC, Ship, Cognex, WMS, Leg, A.I, IMA, Robotics, WAT, Cassette tape

SARASOTA, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- IPG® (Intertape Polymer Group®), a leading manufacturer of highly automated packaging machinery and turnkey solutions, has introduced the new IMA brand E-CO Flex SealMatic.

Key Points: 
  • SARASOTA, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- IPG® (Intertape Polymer Group®), a leading manufacturer of highly automated packaging machinery and turnkey solutions, has introduced the new IMA brand E-CO Flex SealMatic.
  • The E-CO Flex SealMatic is a fully automated case sealer to process FEFCO 201 (RSC) cases, automatically adjusting its mechanical movements according to the case size.
  • The machine can process an extensive range of case sizes, allowing the equipment to seamlessly adjust to the size of each case while closing the case top flaps.
  • “SealMatic stands out for its exceptional design as a fully automatic machine,” states Micah Ordway, IPG Product Manager for Advanced Automation.

Waters Corporation to Present at the Jefferies 2024 Healthcare Conference

Retrieved on: 
月曜日, 5月 13, 2024
Conference, Webcast, WAT, Waters Corporation

MILFORD, Mass., May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2024 Healthcare Conference on Wednesday, June 5th, 2024 at 9:30AM Eastern Time.

Key Points: 
  • MILFORD, Mass., May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2024 Healthcare Conference on Wednesday, June 5th, 2024 at 9:30AM Eastern Time.
  • A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com.
  • A replay of the webcast will be available for 90 days.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on: 
水曜日, 5月 8, 2024
ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points: 
  • MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
  • This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
  • The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
  • The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument

Retrieved on: 
水曜日, 5月 8, 2024
ACT, C-peptide, Chromatography software, Mass, Analytic, Research, LC-MS, Waters Corporation, API, Food, CDS, Mass spectrometry, WAT, Fine chemical

MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid Chromatography (LC) separations portfolio to enable flexible analysis of both small and large molecules across pharmaceutical, food, chemical, and materials applications.

Key Points: 
  • MILFORD, Mass., May 8, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
  • This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution.
  • The ACQUITY QDa II Mass Detector is designed to seamlessly integrate into existing laboratory workflows with the usability and format of a LC detector.
  • The ACQUITY QDa II Mass Detector is designed for compliance-ready deployment on Waters Empower™ Chromatography Data System (CDS) Software.

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

Retrieved on: 
月曜日, 4月 22, 2024
HPS, Safety, LNP, Waters Corporation, Vaccine, Particle size, Therapy, HPLC, Patient, Laboratory, Messenger, WAT

MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.

Key Points: 
  • New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.
  • MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns.
  • Waters GTxResolve Premier SEC Columns support the growing demand for mRNA, LNP, and viral-vector-based therapies.
  • GTxResolve Premier SEC Columns are engineered to reduce problematic non-specific binding, minimize mobile phase method development challenges, and provide higher throughput separation efficiency.

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

Retrieved on: 
月曜日, 4月 22, 2024
HPS, Safety, LNP, Waters Corporation, Vaccine, Particle size, Therapy, HPLC, Patient, Laboratory, Messenger, WAT

MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns. Waters has implemented a unique combination of novel packing materials and MaxPeak™ Premier High-Performance Surface (HPS) technology into the columns to help scientists accelerate the development of gene-based therapeutics, including cell & gene, mRNA and LNPs.

Key Points: 
  • New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics.
  • MILFORD, Mass., April 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today introduced new GTxResolve Premier Size Exclusion Chromatography (SEC) 1000Å 3-micron (3 µm) Columns.
  • Waters GTxResolve Premier SEC 1000Å 3 µm Columns address those challenges by providing higher sensitivity, resolution, and throughput by combining novel particle technology with low adsorption MaxPeak Premier HPS Technology.
  • GTxResolve Premier SEC Columns are engineered to reduce problematic non-specific binding, minimize mobile phase method development challenges, and provide higher throughput separation efficiency.

Waters Corporation Schedules First Quarter 2024 Earnings Conference Call

Retrieved on: 
木曜日, 4月 11, 2024
Webcast, Waters Corporation, WAT

MILFORD, Mass., April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time.

Key Points: 
  • MILFORD, Mass., April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time.
  • A live webcast of the presentation will be available on Waters Investor Relations website at h ttps://ir.waters.com .
  • A replay of the webcast will also be available until at least June 4th, 2024, at midnight Eastern Time.

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors

Retrieved on: 
火曜日, 4月 9, 2024
QA/QC, QC, WAT, Intelligence, HPLC, Laboratory, HPS, Waters Corporation

MILFORD, Mass., and MUNICH, April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of failed runs and out-of-specification results.

Key Points: 
  • New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errorsi.
  • MILFORD, Mass., and MUNICH, April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories.
  • The Alliance iS Bio HPLC System also combines with Waters compliance-ready Empower Chromatography Software to help laboratories collect, manage, and report chromatography test results.
  • It integrates seamlessly with Waters and third-party liquid chromatography instruments to help high-volume QC labs manage operational risk, mitigate disruptions, and increase overall productivity.

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors

Retrieved on: 
火曜日, 4月 9, 2024
QA/QC, QC, WAT, Intelligence, HPLC, Laboratory, HPS, Waters Corporation

MILFORD, Mass., and MUNICH, April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of failed runs and out-of-specification results.

Key Points: 
  • New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errorsi.
  • MILFORD, Mass., and MUNICH, April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories.
  • The Alliance iS Bio HPLC System also combines with Waters compliance-ready Empower Chromatography Software to help laboratories collect, manage, and report chromatography test results.
  • It integrates seamlessly with Waters and third-party liquid chromatography instruments to help high-volume QC labs manage operational risk, mitigate disruptions, and increase overall productivity.

Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges

Retrieved on: 
木曜日, 3月 14, 2024
QC, Comment, GCB, PFAS, Phosphatidylethanolamine, Environment, WAT, Filtration, Risk, European Chemicals Agency, WAX, Carbon, Centrifugation, Workflow, Laboratory, EPA, Waters Corporation, Compensation, Safe Drinking Water Act, Biosolids, Soil, CERCLA, Extraction (chemistry), Cosmetics

MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS). To help ensure accuracy and further confidence in test results, Oasis WAX/GCB and GCB/WAX Cartridges are QC-tested by an accredited laboratory for low residual PFAS, to reduce or eliminate any time spent troubleshooting potential assay contamination.

Key Points: 
  • Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue.
  • MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS).
  • Oasis WAX/GCB & GCB/WAX Cartridges are the latest products within Waters extensive portfolio of PFAS testing solutions.
  • Oasis WAX/GCB and GCB/WAX Cartridges are the latest products within a comprehensive portfolio of PFAS Testing Solutions offered by Waters to support the surging demand for PFAS environmental testing.